Clinical Trial Update: CISCO-21 Prevent and Treat Long COVID-19. [NA]

View source ↗

Summary

Clinical trial CISCO-21, aimed at preventing and treating long COVID-19, has completed. The snippet provides no efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid

Drugs mentioned

• CISCO-21

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Covid19 | NA | Status: COMPLETED